Can Cognitive Behavioural Therapy Help Incarcerated Men Quit Smoking? Efficacy and Predictors of Treatment Outcomes
PriSanTabac
Cognitive Behavioural Therapy for Smoking Cessation in Incarcerated Men: Efficacy and Predictors of Treatment Outcomes
1 other identifier
interventional
202
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether a brief group-based psychological intervention using cognitive-behavioral therapy (CBT) helps people in prison quit smoking. Researchers will compare this intervention to a health education program and a control group (waitlist) to see which approach is most effective. The main questions this study aims to answer are:
- Does the CBT-based group intervention help more participants quit smoking compared to the health education group and the control group?
- Do participants in the CBT-based group intervention smoke fewer cigarettes per day one month after the intervention compared to the other groups?
- Do participants in the CBT-based group intervention have lower nicotine dependence ?
- What individual factors (e.g., motivation to quit, nicotine dependence, craving intensity, self-efficacy, withdrawal symptoms, anxiety, depression, ADHD, and PTSD) predict success in the CBT and Health education groups? Participants will be randomly assigned to one of three groups:
- CBT group: Three group sessions (1.5 hours each) using CBT and motivational approaches to quitting smoking.
- Health education group: One group session (1 hour) providing information on smoking and its health risks.
- Control group: No intervention for three months (waitlist). All participants will complete an initial assessment, attend their assigned group sessions, and return for follow-up visits at 1 month and 3 months. Their smoking status will be measured through self-reports and carbon monoxide (CO) expired levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 7, 2025
CompletedFirst Posted
Study publicly available on registry
March 12, 2025
CompletedStudy Start
First participant enrolled
June 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
September 3, 2025
February 1, 2025
1.2 years
March 7, 2025
August 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Smoking Abstinence Verified by Carbon Monoxide (CO) Measurement at 1-Month Follow-Up
Smoking abstinence will be assessed through self-reported smoking status and verified by exhaled carbon monoxide (CO) levels measured using a CO monitor. Participants who self-report smoking abstinence and have a CO level below 8 parts per million (ppm) will be classified as abstinent. A CO level ≥8 ppm will indicate continued smoking.
baseline to 1-month follow-up
Smoking Abstinence Verified by Carbon Monoxide (CO) Measurement at 3-Month Follow-Up
Smoking abstinence will be assessed through self-reported smoking status and verified by exhaled carbon monoxide (CO) levels measured using a CO monitor. Participants who self-report smoking abstinence and have a CO level below 8 parts per million (ppm) will be classified as abstinent. A CO level ≥8 ppm will indicate continued smoking.
baseline to 3-month follow-up
Secondary Outcomes (10)
Number of Cigarettes Smoked Per Day at 1-Month Follow-Up
Baseline to 1-month follow-up
Number of Cigarettes Smoked Per Day at 3-Month Follow-Up
Baseline to 3-month follow-up
Nicotine Dependence (FTND Score) at 1-Month Follow-Up
Baseline to 1-month follow-up
Nicotine Dependence (FTND Score) at 3-Month Follow-Up
Baseline to 3-month follow-up
Smoking Craving (FTCQ-12 Score) at 1-Month Follow-Up
Baseline to 1-month follow-up
- +5 more secondary outcomes
Study Arms (3)
Cognitive-Behavioral Therapy (CBT) group
EXPERIMENTALParticipants in this group will receive a cognitive-behavioral therapy (CBT)-based intervention designed to help them quit smoking. The intervention consists of three structured group sessions (1.5 hours each) over three weeks, incorporating cognitive-behavioral, motivational, and emotional strategies. The sessions focus on: * Increasing motivation to quit smoking, * Managing cravings and withdrawal symptoms, * Developing coping strategies for stress, * Preventing relapse through behavioral and cognitive techniques. This program is adapted from Richmond et al. (2013) The program is based on Richmond et al. (2013) and has been further adapted for the specific context of this study and to align with current recommendations.
Health Education Group
ACTIVE COMPARATORParticipants in this group will receive a single-session health education program (1 hour) focused on the risks of smoking and the mechanisms of tobacco addiction. The session is conducted in a group format by a psychologist-nurse team and aims to provide participants with knowledge about the effects of smoking on health.
Waitlist Control Group
NO INTERVENTIONParticipants in this group will not receive any intervention during the 3-month study period. They will be placed on a waitlist and will have the opportunity to participate in one of the two interventions (CBT or Health Education or both) after the study follow-up is completed.
Interventions
A structured three-session group intervention (1.5 hours per session over three weeks) using cognitive-behavioral and motivational strategies to enhance motivation, manage cravings, and prevent relapse. Associated Arm: CBT Group
A single-session group intervention (1 hour) providing information on the health risks of tobacco use, addiction mechanisms, and the long-term benefits of quitting smoking. Associated Arm: Health Education Group
Eligibility Criteria
You may qualify if:
- Male individuals currently incarcerated at Maison d'Arrêt Paris-La Santé.
- Current smoker, defined as having smoked daily in the past 30 days, or having an occasional smoking pattern of at least 5 cigarettes during the past 30 days.
- Able to speak and understand French well enough to follow the study procedures and actively participate in group sessions.
- Sentence length of at least 6 months, or if in pretrial detention, having a scheduled trial date within at least 6 months.
You may not qualify if:
- Inability to speak and understand French well enough to follow the study procedures and actively participate in group sessions.
- Sentence length of less than 6 months, or if in pretrial detention, having a scheduled trial date in less than 6 months or no available information about the trial date.
- Severe cognitive impairment that affects comprehension and participation in the study.
- Unstable psychiatric conditions (including acute psychotic disorders, severe mood disorders, severe anxiety disorders).
- Individuals under legal guardianship or conservatorship (e.g., placed under tutelage, curatorship, or temporary guardianship).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier St Annelead
- Paris Nanterre Universitycollaborator
Study Sites (1)
Centre pénitentiaire Paris-La Santé (Paris-La Santé prison)
Paris, Île-de-France Region, 75014, France
Related Publications (1)
Richmond R, Indig D, Butler T, Wilhelm K, Archer V, Wodak A. A randomized controlled trial of a smoking cessation intervention conducted among prisoners. Addiction. 2013 May;108(5):966-74. doi: 10.1111/add.12084. Epub 2013 Mar 11.
PMID: 23228222BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xavier Laqueille, MD, Head of Department
GHU Paris Psychiatrie et Neurosciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2025
First Posted
March 12, 2025
Study Start
June 18, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
September 3, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
Investigators do not plan to share individual participant data (IPD) for this study. The protocol submitted to the Ethics Committee (CPP) does not include any specific provision regarding data sharing, and participants were neither informed nor consented to such use. In accordance with ethical and regulatory requirements, as well as principles of confidentiality and data protection, investigators are therefore unable to make these data available to other researchers.